Qingdao, 19 September 2026 — Qingdao Seawin Biotech held its 2026 New Product Summit and officially commissioned Phase II of its modern industrial park, marking a further step in the company' s transition toward science-driven, targeted marine biostimulants.

At the core of Seawin's innovation is a proprietary marine biotech platform based on customized enzyme engineering, directional enzymolysis and multi-stage purification. By processing kelp, Enteromorpha and other aquatic biomass, the company has established a database of more than 50 marine oligosaccharides and 30 bioactive peptides. Key patented factors — SEA-D30, APAA and GALA — now form the foundation of the upgraded product portfolio:

● Seawinner: Bio-organic fertilizers and seaweed polysaccharide microgranules focused on soil health, root development and stress resilience

● Winsea: Solutions addressing root nourishment, stress resistance, nutrient efficiency, fruit expansion and quality improvement

● HiGood: Products that convert APAA (rooting and drought protection) and GALA (anthocyanin synthesis and coloration) into practical improvements in fertilizer efficiency, stress resilience and fruit quality

Phase II of the industrial park covers 176.9 mu with a total investment exceeding RMB 500 million. Upon commissioning, annual production capacity reaches 5,000 tons of marine biostimulants and 20,000 tons of specialty marine bio-functional fertilizers, strengthening the link between laboratory research and stable commercial supply for global markets.

As the organiser of FSHOW, we are pleased to have SEAWIN Biotech as an exhibitor and look forward to welcoming industry professionals to engage with the company and its latest marine biostimulant solutions at the upcoming edition in Shanghai (24–26 March 2027).

Exhibition Overview

Exhibitor Center

Visitor Center